20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
T-cell modulatory multimeric polypeptides and methods of use thereof
#4802pH-RESPONSIVE SILICA METAL ORGANIC FRAMEWORK NANOPARTICLES FOR DELIVERY OF BIOACTIVE MOLECULES
#4803Sulfoximine glycosidase inhibitors
#4804Tryptamine Prodrugs
#4805AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy (ALD) and/or adrenomyeloneuropathy (AMN)
#4806DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS
#4807TREATING MYELOMAS
#4808Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof
#4809LIQUID PHARMACEUTICAL COMPOSITION
#4810FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
#4811METHODS AND COMPOSITIONS FOR TREATING CONDITIONS USING RECOMBINANT SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS
#4812Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
#4813Chloride salt of TAT-NR2B9C
#4814POLYMERIC NANOPARTICLES AND A PROCESS OF PREPARATION THEREOF
#4815COMPOSITIONS AND METHODS FOR PREVENTING THE PROLIFERATION AND EPITHELIAL-MESENCHYMAL TRANSITION OF EPITHELIAL CELLS
#4816Tumoricidal and antimicrobial compositions and methods
#4817POLYMER AGENTS FOR CARDIOPULMONARY RESUSCITATION
#4818USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#4819COMBINED PHARMACEUTICAL COMPOSITION FOR TREATING SMALL CELL LUNG CANCER
#4820TREATING OF SIDE-EFFECTS RESULTING FROM CHEMODENERVATION
#4821Opioid receptor ligands and methods of using and making same
#4822TRANSDERMAL PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF CANCER
#4823CARBOPLATIN COMPLEX AND PHARMACEUTICAL PREPARATION THEREOF
#4824Calcium lactate compositions and methods of use
#4825POLYMERIC NANOPARTICLES
#4826Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity
#4827Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity
#4828STABLE LIQUID ANTIBODY FORMULATION
#4829SYNERGIST THERAPY FOR ENHANCED DRUG DELIVERY: MAGNETIC FIELD FACILITATED NANOPARTICLE MICROPORATION
#4830Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#4831METHOD FOR DEACETYLATION OF BIOPOLYMERS
#48326-pyrimidin-isoindole derivative as ERK1/2 inhibitor
#4833BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#4834Methods for ensuring resuspension of paliperidone palmitate formulations
#4835Implantable pump for direct sodium removal therapy having on-board analyte sensor
#4836COMPOSITIONS AND METHODS FOR ADMINISTRATION OF THERAPEUTICS
#4837COMBINED PHARMACEUTICAL COMPOSITION
#4838USE OF EPIDERMAL GROWTH FACTOR IN DIABETIC FOOT ULCER TREATMENT
#4839Formulations containing a somatostatin receptor agonist
#4840BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID
#4841Dosing regimens associated with extended release paliperidone injectable formulations
#4842Dosing regimens associated with extended release paliperidone injectable formulations
#4843Treatment of progressive neurodegenerative disease with ibudilast
#4844Inhibition of COVID-19 virus
#4845Cannabidiol preparations and its uses
#4846AMPHIPHILIC PLATINUM (IV) PRODRUG AND CANCER TREATMENT PROCESS
#4847CAPSULE COMPRISING INSULIN-SECRETING CELLS FOR TREATING DIABETES
#4848Liposomes encapsulating adenosine
#4849LIPID NANOPARTICLES
#4850USE OF COMPOSITION FOR REDUCING OR PREVENTING CELL AGING OR REPAIRING CELL WITH DAMAGED MITOCHONDRIA, METHOD OF PREPARING COMPOSITION FOR CELL REPAIRING, CELL REPAIRING METHOD AND METHOD OF SUPPLYING MITOCHONDRIA INTO CELL
#4851Anti-IL36R antibodies
#4852METHODS AND COMPOSITIONS FOR TREATING ALLERGIC OCULAR DISEASES
#4853COMBINATION IMMUNOTHERAPY
#4854COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#4855ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS
#4856Topiramate compositions and methods of making and using the same
#4857ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#4858Therapeutic agent for disc herniation
#4859LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE
#4860Treatment Of Intervertebral Disc Degeneration
#4861USE OF ANNEXIN V AS A METHOD TO BLOCK TUMOR INDUCED IMMUNOSUPPRESSION OF THE INNATE IMMUNE RESPONSE
#4862Pharmaceutical composition with improved stability
#4863ANGIOTENSIN COMPOSITIONS AND METHODS RELATED THERETO
#4864Tumoricidal and antimicrobial compositions and methods
#4865Derivatized chitosan polymers and methods of treating vascular disorders
#4866Stable antiemetic emulsions
#4867COMPOSITIONS AND METHODS OF TREATING CANCER
#4868METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING BCN057 OR BCN512
#4869PLASMA KALLIKREIN INHIBITORS AND METHODS OF USE THEREOF IN OCULAR DISORDERS
#4870COMPOSITIONS AND METHODS FOR CANCER THERAPY
#4871TUMESCENT INFILTRATION DRUG DELIVERY OF CANNABINOIDS
#4872COMPOSITIONS FOR USE IN SURGERY
#4873Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
#4874METHODS OF ADMINISTERING AN ARIPIPRAZOLE INJECTABLE PREPARATION
#4875MUC16 specific chimeric antigen receptors and uses thereof
#4876MUC16 specific chimeric antigen receptors and uses thereof
#4877ANTI-CD40 ANTIBODIES
#4878Sensitizing cells to proton radiation
#4879Engineered chimeric fusion protein compositions and methods of use thereof
#4880Peptide vaccine formulations and use thereof for inducing an immune response
#4881DOSING REGIMEN
#4882Irisin improves placental function during pregnancy
#4883ACELLULAR INTRAVENOUS INFUSION INCLUDING MESENCHYMAL STEM CELL GROWTH FACTORS AND EXOSOMES
#4884PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF
#4885METHODS FOR TREATING NON-CANCEROUS DISORDERS USING HEMATOPOIETIC CELLS
#4886STABILIZED AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF NEUROLOGICAL, MUSCULAR AND INFERTILITY DISEASES OR CONDITIONS
#4887OXYGEN REACTIVE POLYMERS FOR TREATMENT OF TRAUMATIC BRAIN INJURY
#4888Particle-mediated delivery of biologics
#4889Methods For The Treatment Of APOC3-Related Diseases And Disorders
#4890Injectable bifunctional hydrogel with antibacterial activity as well as the preparative method and the use thereof
#4891PHARMACEUTICAL COMPOSITION AND METHOD FOR NEOANGIOGENESIS/REVASCULARIZATION USEFUL IN TREATING ISCHEMIC HEART DISEASE
#4892METHODS OF TESTOSTERONE THERAPY
#4893DOSING REGIMEN OF SEDATIVE
#4894Methods and compositions comprising a KRASG12C inhibitor and a PD-L1 binding antagonist for treating lung cancer
#4895Aripiprazole dosing strategy
#4896NEDOCROMIL SODIUM TO PREVENT, LIMIT ONSET, AND /OR TREAT PANCREATIC CANCER
#4897Formulations of hydroxypyridonate actinide/lanthanide decorporation agents
#4898THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING LYMPHOMA USING 6,8-BISBENZYLTHIO-OCTANOIC ACID
#4899FORMULATIONS AND METHODS FOR TREATING ACUTE CANNABINOID OVERDOSE
#4900PARENTERAL DELIVERY OF AVIZAFONE
#4901More potent and less toxic formulations of epinephrine and methods of medical use
#4902Process for the preparation of drug loaded microparticles
#4903STABLE LIQUID COMPOSITIONS OF PEMETREXED
#4904Polymer particles
#4905Anti-respiratory syncytial virus antibodies, and methods of their generation and use
#4906Long-acting VEGF inhibitors for intraocular neovascularization
#4907HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS
#4908siRNA Inhibition Of Human Antigen R Expression For Treatment of Cancer
#4909PRESERVED FORMULATIONS
#4910DUODENAL ADMINISTRATION OF BOTULINUM TOXIN
#4911NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR
#4912USE OF PEPTIDE DERIVED FROM H-REV107
#4913METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#4914Method for treating psoriasis
#4915ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING
#4916Water dissolvable macrocyclic lactone cyclodextrin complexes
#4917Prodrug salts
#4918FULVESTRANT FORMULATIONS
#4919COMBINED THERAPY FOR NMDAR ANTAGONIST-RESPONSIVE NEUROPSYCHIATRIC DISORDERS
#4920Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
#4921Combination of antibody-drug conjugate and immune checkpoint inhibitor
#4922USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS
#4923Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA Gene
#4924Formulations, methods, kits, and dosage forms
#4925METHOD OF INITIATING AND ESCALATING SOTALOL HYDROCHLORIDE DOSING
#4926COMBINATION THERAPEUTICS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE AND OTHER DISEASES
#4927Dental Local Anesthetic Solution
#4928SUSPENSION FORMULATIONS OF HIGH LOAD DISPERSIONS
#4929Sterile aztreonam package
#4930TELOMERASE-CONTAINING EXOSOMES FOR TREATMENT OF DISEASES ASSOCIATED WITH AGING AND AGE-RELATED ORGAN DYSFUNCTION
#4931USE OF ISATUXIMAB FOR THE TREATMENT OF MULTIPLE MYELOMA
#4932Anti-PD1 and anti-CTLA4 antibodies
#4933GIP receptor agonist peptide compounds and uses thereof
#4934Crystalline PPARδ agonist
#4935PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE
#4936COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER
#4937METHOD FOR ELICITING AN IMMUNE RESPONSE TO AN IMMUNOGEN
#4938Herpesvirus compositions and related methods
#4939TREATMENT OF SANFILIPPO SYNDROME TYPE B
#4940Methods and compositions for CNS delivery of heparan N-sulfatase
#4941HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT EDEMA
#4942Reconstituted high density lipoprotein formulation and production method thereof
#4943Vasopressin formulations for use in treatment of hypotension
#4944ONCOLYTIC VIRUSES TARGETING STAT3
#4945ONCOLYTIC VIRUSES TARGETING STAT3
#4946TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING
#4947Early apoptotic cells for use treating sepsis
#4948P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION
#4949Methods for Treatment of Alport Syndrome
#4950METHOD FOR HYDRATING LYOPHILIZED CYCLOPHOSPHAMIDE COMPOSITION AND PRODUCT THEREOF
#4951P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD
#4952INJECTABLE FORMULATIONS
#4953Ifetroban Treatment for Systemic Sclerosis
#4954METHODS OF TREATING AND PREVENTING NEURODEGENERATIVE DISEASES WITH HGF ACTIVATING COMPOUNDS
#4955Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
#4956A FORMULATION FOR IMPROVING SEIZURE CONTROL
#4957P-ethoxy nucleic acids for STAT3 inhibition
#4958METHODS AND MATERIALS FOR ACTIVATING AN INTERNAL RIBOSOME ENTRY SITE IN EXON 5 OF THE DMD GENE
#4959METHOD FOR LARGE-SCALE PRODUCTION OF ALLOSPECIFIC TYPE 1 REGULATORY TREGS (TR1) STABLE IN THE PRESENCE OF PROINFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#4960METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR
#4961Nitrogen-containing fused heterocyclic SHP2 inhibitor compound, preparation method, and use
#4962Conformal coating of cells for immunoisolation
#4963PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG, AND PREPARATION METHOD THEREFOR
#4964Compositions and methods for treatment of homocystinuria
#4965COMPOSITION COMPRISING ALBUMIN-COUPLED SLIT3 LRRD2 FOR PREVENTION OR TREATMENT OF MUSCLE DISEASE
#4966Sustained-release lipid preformulation and pharmaceutical composition for sustained-release injection in form of lipid solution containing same
#4967USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
#4968METHOD FOR TREATING OSTEOARTHRITIS WITH A COMBINATION OF MESENCHYMAL STEM CELL EXOSOMES, SYNOVIAL MESENCYMAL STEM CELLS, AND SCAFFOLDS
#4969REGENERATIVE CO2 TREATMENT SYSTEM AND METHOD
#4970S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS
#4971EXTRAHEPATIC DELIVERY
#4972Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
#4973INJECTABLE COMPOSITION FOR INDUCING LIPOLYSIS AND METHOD USING THE SAME
#4974LIPID COMPOSITIONS WITH HIGH DHA CONTENT
#4975Ready-to-use injectable formulations
#4976Treatment of acute myeloid leukemia (AML) with venetoclax failure
#4977Methods of treating injuries or conditions related to CNS edema
#4978TRIPLE COMBINATION FORMULATION FOR TREATMENT OF CHRONIC PAIN
#4979MICROFLUIDICS DEVICE FOR FABRICATION OF LARGE, UNIFORM, INJECTABLE HYDROGEL MICROPARTICLES FOR CELL ENCAPSULATION
#4980STABILIZED Fc FUSION PROTEIN SOLUTIONS
#4981Hematocrit Modulation Through Needle Assisted Jet Injection of Testosterone
#4982BALLISTIC DELIVERY METHOD AND SYSTEM FOR INJECTABLE FORMULATIONS
#4983EXOSOMES AND MICRO-RIBONUCLEIC ACIDS FOR TISSUE REGENERATION
#4984METHODS FOR ALTERING BODY COMPOSITION BY ADMINISTERING A GDF8 INHIBITOR AND AN ACTIVIN A INHIBITOR
#4985Method of injecting octreotide acetate into the body
#4986STABILIZED RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN COMPOSITIONS
#4987Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
#4988Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
#4989Process for preparing an immunoglobulin preparation
#4990Compositions and methods for generating an immune response to hepatitis B virus
#4991Dry Pharmaceutical Formulations of CNP Conjugates
#4992Injectable garlic formulation and a method of using the injectable garlic formulation
#4993METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS
#4994COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#4995HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
#4996COMPOSITION FOR INCREASING PREGNANCY RATE OF RUMINANTS AND PREPARATION METHOD AND APPLICATION THEREOF
#4997ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS
#4998Compositions of Glycerol and /or Non-Toxic Amino Acids for Inhibiting and Destroying Biofilm, including Related Methods
#4999DEZOCINE DERIVATIVE AND MEDICAL USE THEREOF
#5000Composition of docetaxel liposomal injection with high drug loading
#5001TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL ADMINISTRATION OF TREHALOSE
#5002Stromal stem cells
#5003BIOSYNTHETIC MATERIALS AND METHODS FOR MULTIDIRECTIONAL BIOTRANSPORTATION
#5004Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use
#5005MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS
#5006EMBOLIC MICROSPHERES
#5007LIVER SPECIFIC DELIVERY OF MESSENGER RNA
#5008LIVER SPECIFIC DELIVERY OF MESSENGER RNA
#5009LIVER SPECIFIC DELIVERY OF MESSENGER RNA
#5010Lipid nanoparticle compositions and methods for mRNA delivery
#5011LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#5012Lipid nanoparticle compositions and methods for MRNA delivery
#5013Immunoswitch nanoparticles for reprogrammed T cell responses
#5014MAYTANSINOID DERIVATIVES WITH SELF-IMMOLATIVE PEPTIDE LINKERS AND CONJUGATES THEREOF
#5015ANTIBODY FORMULATIONS
#5016CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY
#5017COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING VIRAL INFECTIONS, AND METHODS OF USING THE SAME
#5018METHODS OF PROMOTING REMYELINATION
#5019Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative conditions
#5020METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR
#5021POLYNUCLEOTIDES ENCODING VERY LONG-CHAIN ACYL-COA DEHYDROGENASE FOR THE TREATMENT OF VERY LONG-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
#502219-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof
#5023Beta-hydroxybutyrate mixed salt compositions and methods of use
#5024Method of treating cancer using selective estrogen receptor modulators
#5025Compositions comprising ephedrine or an ephedrine salt and methods of making and using same
#5026Epinephrine compositions and containers
#5027Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors
#5028Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
#5029Lipid nanoparticle compositions and methods for mRNA delivery
#5030BIOORTHOGONAL COMPOSITIONS
#5031POLYETHYLENE GLYCOL CONJUGATED DRUG AND ITS PREPARATION METHOD AND USE
#5032METHODS OF TREATMENT FOR KIDNEY DISEASE
#5033Hard tissue therapeutics
#5034TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY
#5035Method for Producing an Exosome Containing Agent for Metastasis Suppression
#5036Method of reconstituting liposomal annamycin
#5037METHODS FOR TREATING CHEMORESISTANT CANCER-INITIATING CELLS
#5038Antidotes to Cyanide Poisoning
#5039Microparticles comprising PCL and uses thereof
#5040METHOD FOR IMPROVING STORAGE STABILITY
#5041Medroxyprogesterone acetate injectable compositions and methods of use
#5042Reversal of General Anesthesia by Administration of Methylphenidate, Amphetamine, Modafinil, Amantadine, and/or Caffeine
#5043ANTI-CD40 ANTIBODIES FOR USE IN TREATMENT OF HIDRADENITIS
#5044TREATING REFRACTORY MIGRAINE
#5045BH4 Stabilized Peptides And Uses Thereof
#5046Inhibition of pulmonary fibrosis with nutlin-3A and peptides
#5047Compounds active towards nuclear receptors
#5048Piperazine derivatives, pharmaceutical compositions and methods of use thereof
#5049METHOD FOR IMPROVING NEUROLOGICAL FUNCTION IN MPSI AND MPSII AND OTHER NEUROLOGICAL DISORDERS
#5050COMPOSITIONS FOR THE TREATMENT OF DISEASE
#5051THERMOREVERSIBLE COMPOSITIONS FOR ADMINISTRATION OF THERAPEUTIC AGENTS
#5052Injectable preparation
#5053COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION
#5054Methods of treatment for cervical dystonia
#5055SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF
#5056Insulin formulations and uses in infusion devices
#5057METHODS AND COMPOSITIONS FOR TREATMENT OF BONE DEFECTS WITH PLACENTAL CELL POPULATIONS
#5058OSTEOBLAST CELL-MIXTURE, AND IMPLEMENTATIONS THEREOF
#5059METHODS AND COMPOSITIONS RELATING TO MESENCHYMAL STEM CELL EXOSOMES
#5060SYSTEMIC, ALLOGENIC STEM CELL THERAPIES FOR TREATMENT OF DISEASES IN ANIMALS
#5061Method for treating osteoarthritis
#5062Composition for treating joint disease and kit containing same
#5063METHOD OF TREATMENT AND PHARMACEUTICAL DOSAGE FORM
#5064Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO
#5065COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS THEREOF
#5066INJECTABLE SUSTAINED-RELEASE FORMULATIONS FOR TREATMENT OF JOINT PAIN AND INFLAMMATION
#5067Precipitation resistant small molecule drug formulations
#5068PHARMACEUTICAL COMPOSITIONS FOR SUBCUTANEOUS ADMINISTRATION OF LEVOSIMENDAN
#5069RESIQUIMOD TOPICAL AND INJECTABLE COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC SKIN CONDITIONS
#5070Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
#5071TREATMENT OF RESTENOSIS USING TEMSIROLIMUS
#5072FABP4 as a therapeutic target in skin diseases
#5073Treatment of Bladder Cancer by Local Administration of Taxane Particles
#5074LEVOTHYROXINE LIQUID FORMULATIONS
#5075METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 IN COMBINATION WITH IMMUNE CHECKPOINT MODULATORS
#5076METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10
#5077Parenteral formulations
#5078Edds chelated nanoceria with catalase-like activity
#5079LYOPHILIZED FORMULATION OF TAT-NR2B9C WITH ACETYLATION SCAVENGER
#5080METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#5081ANTISENSE OLIGONUCLEOTIDES TARGETING SCN2A RETAINED INTRONS
#50825-halouracil-modified microRNAs and their use in the treatment of cancer
#5083OLIGONUCLEOTIDES FOR HTT-1A MODULATION
#5084Stromal stem cells
#5085PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USED OF THE SAME IN IMMUNOTHERAPY
#5086THERAPEUTIC COMBINATION AND METHOD FOR TREATING CANCER
#5087Method of Treating Signs and Symptoms of Osteoarthritis
#5088Methods for modulating an immune response
#5089COMPOUND COMPRISING MULTIVALENT SIALYLOLIGOSACCHARIDE RESIDUES, AND COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTION DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT
#5090N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compounds as stimulators of the production of retinal precursor cells for the treatment of neuroretinal diseases
#5091COMPOUNDS FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF NEURORETINAL DISEASES
#5092PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS
#5093Pharmaceutical preparation containing polyethylene gylcol loxenatide and preparation method thereof
#5094Glycemic control using intrinsic factor bound to a vitamin Bconjugate of a glucagon-like peptide-1 receptor agonist
#5095Targeting microbubbles
#5096COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
#5097METHODS FOR TREATING HEADACHE
#5098METHODS AND COMPOSITIONS FOR TREATING CHRONIC LUNG DISEASES
#5099PHARMACEUTICAL COMPOSITION, COMPRISING INHIBITORY PEPTIDE AGAINST FAS SIGNALING, FOR PREVENTION OR TREATMENT OF OBESITY, FATTY LIVER, OR STEATOHEPATITIS
#5100COMPOSITION FOR USE IN TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA